nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—cardiac ventricle—dilated cardiomyopathy	0.152	0.317	CbGeAlD
Tyloxapol—LPL—myocardium—dilated cardiomyopathy	0.143	0.298	CbGeAlD
Tyloxapol—LPL—heart—dilated cardiomyopathy	0.1	0.208	CbGeAlD
Tyloxapol—LPL—cardiac atrium—dilated cardiomyopathy	0.0855	0.178	CbGeAlD
Tyloxapol—LPL—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.0514	0.0991	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.0396	0.0762	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.0343	0.0662	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.0325	0.0627	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ZIC3—dilated cardiomyopathy	0.0286	0.0551	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LMNA—dilated cardiomyopathy	0.0233	0.0449	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SCN5A—dilated cardiomyopathy	0.0217	0.0417	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.0216	0.0415	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.0203	0.0392	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—FAS—dilated cardiomyopathy	0.0203	0.0391	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0193	0.0373	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0182	0.035	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.0139	0.0269	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—FAS—dilated cardiomyopathy	0.0136	0.0262	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.0133	0.0256	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—AGT—dilated cardiomyopathy	0.0128	0.0246	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00913	0.0176	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.00879	0.0169	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—dilated cardiomyopathy	0.00862	0.0166	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ANKRD1—dilated cardiomyopathy	0.00861	0.0166	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TAZ—dilated cardiomyopathy	0.0081	0.0156	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SDHA—dilated cardiomyopathy	0.00732	0.0141	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—dilated cardiomyopathy	0.00578	0.0111	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00571	0.011	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CD36—dilated cardiomyopathy	0.00487	0.00939	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAC1—dilated cardiomyopathy	0.00459	0.00885	CbGpPWpGaD
Tyloxapol—LPL—Disease—NPPA—dilated cardiomyopathy	0.00448	0.00863	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00447	0.00861	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00435	0.00838	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSEN2—dilated cardiomyopathy	0.00434	0.00835	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00392	0.00755	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAF1—dilated cardiomyopathy	0.00304	0.00586	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00304	0.00585	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.0027	0.00519	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.0027	0.00519	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00251	0.00483	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00243	0.00468	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAC1—dilated cardiomyopathy	0.00218	0.0042	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—dilated cardiomyopathy	0.00209	0.00402	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00207	0.00399	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—dilated cardiomyopathy	0.00199	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—dilated cardiomyopathy	0.00199	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00197	0.00379	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD36—dilated cardiomyopathy	0.00194	0.00373	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AGT—dilated cardiomyopathy	0.00174	0.00336	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00169	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00153	0.00294	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGT—dilated cardiomyopathy	0.00146	0.00281	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAF1—dilated cardiomyopathy	0.00145	0.00279	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00101	0.00195	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—dilated cardiomyopathy	0.000991	0.00191	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000694	0.00134	CbGpPWpGaD
